Global Antiretroviral Agent Supply, Demand and Key Producers, 2024-2030

Description

The global Antiretroviral Agent market size is expected to reach $ 62660 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The clinical use of antiretroviral agents involves a pathogenesis-based, combination treatment approach. Increase in the number of chronic diseases, HIV infections will lead to more medicinal development. The surge for anti-resistant medicines has been in demand.  In addition as monoclonal antibodies demand increases, the growth for the antiretroviral (ARV) agents market will spike its rate, demand in personalized medicines has increased bio production, accelerating antiretroviral (ARV) demand.

This report studies the global Antiretroviral Agent production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antiretroviral Agent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiretroviral Agent that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antiretroviral Agent total production and demand, 2019-2030, (K Units)
Global Antiretroviral Agent total production value, 2019-2030, (USD Million)
Global Antiretroviral Agent production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Antiretroviral Agent consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Antiretroviral Agent domestic production, consumption, key domestic manufacturers and share
Global Antiretroviral Agent production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Antiretroviral Agent production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Antiretroviral Agent production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Antiretroviral Agent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare, Gilead Sciences, GlaxoSmithKline, Merck Sharp and Dohme, Bristol-Myers Squibb, Janssen Pharmaceuticals, Pfizer, Boehringer Ingelheim and AbbVie, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antiretroviral Agent market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Antiretroviral Agent Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Antiretroviral Agent Market, Segmentation by Type
    Nucleoside Reverse Transcriptase Inhibitors
    Protease Inhibitors
    HIV Integrase Strand Transfer Inhibitors
    Non-Nucleoside Reverse Transcriptase Inhibitors
    Entry Inhibitors—CCR5 Co-Receptor Antagonist
    Fusion Inhibitors
    Others

Global Antiretroviral Agent Market, Segmentation by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

Companies Profiled:
    ViiV Healthcare
    Gilead Sciences
    GlaxoSmithKline
    Merck Sharp and Dohme
    Bristol-Myers Squibb
    Janssen Pharmaceuticals
    Pfizer
    Boehringer Ingelheim
    AbbVie
    Genentech
    Mylan

Key Questions Answered
1. How big is the global Antiretroviral Agent market?
2. What is the demand of the global Antiretroviral Agent market?
3. What is the year over year growth of the global Antiretroviral Agent market?
4. What is the production and production value of the global Antiretroviral Agent market?
5. Who are the key producers in the global Antiretroviral Agent market?

Table of Contents

1 Supply Summary
    1.1 Antiretroviral Agent Introduction
    1.2 World Antiretroviral Agent Supply & Forecast
        1.2.1 World Antiretroviral Agent Production Value (2019 & 2023 & 2030)
        1.2.2 World Antiretroviral Agent Production (2019-2030)
        1.2.3 World Antiretroviral Agent Pricing Trends (2019-2030)
    1.3 World Antiretroviral Agent Production by Region (Based on Production Site)
        1.3.1 World Antiretroviral Agent Production Value by Region (2019-2030)
        1.3.2 World Antiretroviral Agent Production by Region (2019-2030)
        1.3.3 World Antiretroviral Agent Average Price by Region (2019-2030)
        1.3.4 North America Antiretroviral Agent Production (2019-2030)
        1.3.5 Europe Antiretroviral Agent Production (2019-2030)
        1.3.6 China Antiretroviral Agent Production (2019-2030)
        1.3.7 Japan Antiretroviral Agent Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antiretroviral Agent Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Antiretroviral Agent Major Market Trends

2 Demand Summary
    2.1 World Antiretroviral Agent Demand (2019-2030)
    2.2 World Antiretroviral Agent Consumption by Region
        2.2.1 World Antiretroviral Agent Consumption by Region (2019-2024)
        2.2.2 World Antiretroviral Agent Consumption Forecast by Region (2025-2030)
    2.3 United States Antiretroviral Agent Consumption (2019-2030)
    2.4 China Antiretroviral Agent Consumption (2019-2030)
    2.5 Europe Antiretroviral Agent Consumption (2019-2030)
    2.6 Japan Antiretroviral Agent Consumption (2019-2030)
    2.7 South Korea Antiretroviral Agent Consumption (2019-2030)
    2.8 ASEAN Antiretroviral Agent Consumption (2019-2030)
    2.9 India Antiretroviral Agent Consumption (2019-2030)

3 World Antiretroviral Agent Manufacturers Competitive Analysis
    3.1 World Antiretroviral Agent Production Value by Manufacturer (2019-2024)
    3.2 World Antiretroviral Agent Production by Manufacturer (2019-2024)
    3.3 World Antiretroviral Agent Average Price by Manufacturer (2019-2024)
    3.4 Antiretroviral Agent Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Antiretroviral Agent Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Antiretroviral Agent in 2023
        3.5.3 Global Concentration Ratios (CR8) for Antiretroviral Agent in 2023
    3.6 Antiretroviral Agent Market: Overall Company Footprint Analysis
        3.6.1 Antiretroviral Agent Market: Region Footprint
        3.6.2 Antiretroviral Agent Market: Company Product Type Footprint
        3.6.3 Antiretroviral Agent Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Antiretroviral Agent Production Value Comparison
        4.1.1 United States VS China: Antiretroviral Agent Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Antiretroviral Agent Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Antiretroviral Agent Production Comparison
        4.2.1 United States VS China: Antiretroviral Agent Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Antiretroviral Agent Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Antiretroviral Agent Consumption Comparison
        4.3.1 United States VS China: Antiretroviral Agent Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Antiretroviral Agent Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Antiretroviral Agent Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Antiretroviral Agent Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Antiretroviral Agent Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Antiretroviral Agent Production (2019-2024)
    4.5 China Based Antiretroviral Agent Manufacturers and Market Share
        4.5.1 China Based Antiretroviral Agent Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Antiretroviral Agent Production Value (2019-2024)
        4.5.3 China Based Manufacturers Antiretroviral Agent Production (2019-2024)
    4.6 Rest of World Based Antiretroviral Agent Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Antiretroviral Agent Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Antiretroviral Agent Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Antiretroviral Agent Production (2019-2024)

5 Market Analysis by Type
    5.1 World Antiretroviral Agent Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Nucleoside Reverse Transcriptase Inhibitors
        5.2.2 Protease Inhibitors
        5.2.3 HIV Integrase Strand Transfer Inhibitors
        5.2.4 Non-Nucleoside Reverse Transcriptase Inhibitors
        5.2.5 Entry Inhibitors—CCR5 Co-Receptor Antagonist
        5.2.6 Fusion Inhibitors
        5.2.7 Others
    5.3 Market Segment by Type
        5.3.1 World Antiretroviral Agent Production by Type (2019-2030)
        5.3.2 World Antiretroviral Agent Production Value by Type (2019-2030)
        5.3.3 World Antiretroviral Agent Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Antiretroviral Agent Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Antiretroviral Agent Production by Application (2019-2030)
        6.3.2 World Antiretroviral Agent Production Value by Application (2019-2030)
        6.3.3 World Antiretroviral Agent Average Price by Application (2019-2030)

7 Company Profiles
    7.1 ViiV Healthcare
        7.1.1 ViiV Healthcare Details
        7.1.2 ViiV Healthcare Major Business
        7.1.3 ViiV Healthcare Antiretroviral Agent Product and Services
        7.1.4 ViiV Healthcare Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 ViiV Healthcare Recent Developments/Updates
        7.1.6 ViiV Healthcare Competitive Strengths & Weaknesses
    7.2 Gilead Sciences
        7.2.1 Gilead Sciences Details
        7.2.2 Gilead Sciences Major Business
        7.2.3 Gilead Sciences Antiretroviral Agent Product and Services
        7.2.4 Gilead Sciences Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Gilead Sciences Recent Developments/Updates
        7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.3 GlaxoSmithKline
        7.3.1 GlaxoSmithKline Details
        7.3.2 GlaxoSmithKline Major Business
        7.3.3 GlaxoSmithKline Antiretroviral Agent Product and Services
        7.3.4 GlaxoSmithKline Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 GlaxoSmithKline Recent Developments/Updates
        7.3.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.4 Merck Sharp and Dohme
        7.4.1 Merck Sharp and Dohme Details
        7.4.2 Merck Sharp and Dohme Major Business
        7.4.3 Merck Sharp and Dohme Antiretroviral Agent Product and Services
        7.4.4 Merck Sharp and Dohme Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Merck Sharp and Dohme Recent Developments/Updates
        7.4.6 Merck Sharp and Dohme Competitive Strengths & Weaknesses
    7.5 Bristol-Myers Squibb
        7.5.1 Bristol-Myers Squibb Details
        7.5.2 Bristol-Myers Squibb Major Business
        7.5.3 Bristol-Myers Squibb Antiretroviral Agent Product and Services
        7.5.4 Bristol-Myers Squibb Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Bristol-Myers Squibb Recent Developments/Updates
        7.5.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.6 Janssen Pharmaceuticals
        7.6.1 Janssen Pharmaceuticals Details
        7.6.2 Janssen Pharmaceuticals Major Business
        7.6.3 Janssen Pharmaceuticals Antiretroviral Agent Product and Services
        7.6.4 Janssen Pharmaceuticals Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Janssen Pharmaceuticals Recent Developments/Updates
        7.6.6 Janssen Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 Pfizer
        7.7.1 Pfizer Details
        7.7.2 Pfizer Major Business
        7.7.3 Pfizer Antiretroviral Agent Product and Services
        7.7.4 Pfizer Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Pfizer Recent Developments/Updates
        7.7.6 Pfizer Competitive Strengths & Weaknesses
    7.8 Boehringer Ingelheim
        7.8.1 Boehringer Ingelheim Details
        7.8.2 Boehringer Ingelheim Major Business
        7.8.3 Boehringer Ingelheim Antiretroviral Agent Product and Services
        7.8.4 Boehringer Ingelheim Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Boehringer Ingelheim Recent Developments/Updates
        7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.9 AbbVie
        7.9.1 AbbVie Details
        7.9.2 AbbVie Major Business
        7.9.3 AbbVie Antiretroviral Agent Product and Services
        7.9.4 AbbVie Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 AbbVie Recent Developments/Updates
        7.9.6 AbbVie Competitive Strengths & Weaknesses
    7.10 Genentech
        7.10.1 Genentech Details
        7.10.2 Genentech Major Business
        7.10.3 Genentech Antiretroviral Agent Product and Services
        7.10.4 Genentech Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Genentech Recent Developments/Updates
        7.10.6 Genentech Competitive Strengths & Weaknesses
    7.11 Mylan
        7.11.1 Mylan Details
        7.11.2 Mylan Major Business
        7.11.3 Mylan Antiretroviral Agent Product and Services
        7.11.4 Mylan Antiretroviral Agent Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Mylan Recent Developments/Updates
        7.11.6 Mylan Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antiretroviral Agent Industry Chain
    8.2 Antiretroviral Agent Upstream Analysis
        8.2.1 Antiretroviral Agent Core Raw Materials
        8.2.2 Main Manufacturers of Antiretroviral Agent Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Antiretroviral Agent Production Mode
    8.6 Antiretroviral Agent Procurement Model
    8.7 Antiretroviral Agent Industry Sales Model and Sales Channels
        8.7.1 Antiretroviral Agent Sales Model
        8.7.2 Antiretroviral Agent Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Antiretroviral Agent Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Antiretroviral Agent Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Antiretroviral Agent Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Antiretroviral Agent Production Value Market Share by Region (2019-2024)
    Table 5. World Antiretroviral Agent Production Value Market Share by Region (2025-2030)
    Table 6. World Antiretroviral Agent Production by Region (2019-2024) & (K Units)
    Table 7. World Antiretroviral Agent Production by Region (2025-2030) & (K Units)
    Table 8. World Antiretroviral Agent Production Market Share by Region (2019-2024)
    Table 9. World Antiretroviral Agent Production Market Share by Region (2025-2030)
    Table 10. World Antiretroviral Agent Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Antiretroviral Agent Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Antiretroviral Agent Major Market Trends
    Table 13. World Antiretroviral Agent Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Antiretroviral Agent Consumption by Region (2019-2024) & (K Units)
    Table 15. World Antiretroviral Agent Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Antiretroviral Agent Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Antiretroviral Agent Producers in 2023
    Table 18. World Antiretroviral Agent Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Antiretroviral Agent Producers in 2023
    Table 20. World Antiretroviral Agent Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Antiretroviral Agent Company Evaluation Quadrant
    Table 22. World Antiretroviral Agent Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Antiretroviral Agent Production Site of Key Manufacturer
    Table 24. Antiretroviral Agent Market: Company Product Type Footprint
    Table 25. Antiretroviral Agent Market: Company Product Application Footprint
    Table 26. Antiretroviral Agent Competitive Factors
    Table 27. Antiretroviral Agent New Entrant and Capacity Expansion Plans
    Table 28. Antiretroviral Agent Mergers & Acquisitions Activity
    Table 29. United States VS China Antiretroviral Agent Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Antiretroviral Agent Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Antiretroviral Agent Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Antiretroviral Agent Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Antiretroviral Agent Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Antiretroviral Agent Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Antiretroviral Agent Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Antiretroviral Agent Production Market Share (2019-2024)
    Table 37. China Based Antiretroviral Agent Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Antiretroviral Agent Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Antiretroviral Agent Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Antiretroviral Agent Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Antiretroviral Agent Production Market Share (2019-2024)
    Table 42. Rest of World Based Antiretroviral Agent Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Antiretroviral Agent Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Antiretroviral Agent Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Antiretroviral Agent Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Antiretroviral Agent Production Market Share (2019-2024)
    Table 47. World Antiretroviral Agent Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Antiretroviral Agent Production by Type (2019-2024) & (K Units)
    Table 49. World Antiretroviral Agent Production by Type (2025-2030) & (K Units)
    Table 50. World Antiretroviral Agent Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Antiretroviral Agent Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Antiretroviral Agent Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Antiretroviral Agent Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Antiretroviral Agent Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Antiretroviral Agent Production by Application (2019-2024) & (K Units)
    Table 56. World Antiretroviral Agent Production by Application (2025-2030) & (K Units)
    Table 57. World Antiretroviral Agent Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Antiretroviral Agent Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Antiretroviral Agent Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Antiretroviral Agent Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
    Table 62. ViiV Healthcare Major Business
    Table 63. ViiV Healthcare Antiretroviral Agent Product and Services
    Table 64. ViiV Healthcare Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. ViiV Healthcare Recent Developments/Updates
    Table 66. ViiV Healthcare Competitive Strengths & Weaknesses
    Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 68. Gilead Sciences Major Business
    Table 69. Gilead Sciences Antiretroviral Agent Product and Services
    Table 70. Gilead Sciences Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Gilead Sciences Recent Developments/Updates
    Table 72. Gilead Sciences Competitive Strengths & Weaknesses
    Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 74. GlaxoSmithKline Major Business
    Table 75. GlaxoSmithKline Antiretroviral Agent Product and Services
    Table 76. GlaxoSmithKline Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. GlaxoSmithKline Recent Developments/Updates
    Table 78. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 79. Merck Sharp and Dohme Basic Information, Manufacturing Base and Competitors
    Table 80. Merck Sharp and Dohme Major Business
    Table 81. Merck Sharp and Dohme Antiretroviral Agent Product and Services
    Table 82. Merck Sharp and Dohme Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Merck Sharp and Dohme Recent Developments/Updates
    Table 84. Merck Sharp and Dohme Competitive Strengths & Weaknesses
    Table 85. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 86. Bristol-Myers Squibb Major Business
    Table 87. Bristol-Myers Squibb Antiretroviral Agent Product and Services
    Table 88. Bristol-Myers Squibb Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Bristol-Myers Squibb Recent Developments/Updates
    Table 90. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 91. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 92. Janssen Pharmaceuticals Major Business
    Table 93. Janssen Pharmaceuticals Antiretroviral Agent Product and Services
    Table 94. Janssen Pharmaceuticals Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Janssen Pharmaceuticals Recent Developments/Updates
    Table 96. Janssen Pharmaceuticals Competitive Strengths & Weaknesses
    Table 97. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 98. Pfizer Major Business
    Table 99. Pfizer Antiretroviral Agent Product and Services
    Table 100. Pfizer Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Pfizer Recent Developments/Updates
    Table 102. Pfizer Competitive Strengths & Weaknesses
    Table 103. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 104. Boehringer Ingelheim Major Business
    Table 105. Boehringer Ingelheim Antiretroviral Agent Product and Services
    Table 106. Boehringer Ingelheim Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Boehringer Ingelheim Recent Developments/Updates
    Table 108. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 109. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 110. AbbVie Major Business
    Table 111. AbbVie Antiretroviral Agent Product and Services
    Table 112. AbbVie Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. AbbVie Recent Developments/Updates
    Table 114. AbbVie Competitive Strengths & Weaknesses
    Table 115. Genentech Basic Information, Manufacturing Base and Competitors
    Table 116. Genentech Major Business
    Table 117. Genentech Antiretroviral Agent Product and Services
    Table 118. Genentech Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Genentech Recent Developments/Updates
    Table 120. Mylan Basic Information, Manufacturing Base and Competitors
    Table 121. Mylan Major Business
    Table 122. Mylan Antiretroviral Agent Product and Services
    Table 123. Mylan Antiretroviral Agent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 124. Global Key Players of Antiretroviral Agent Upstream (Raw Materials)
    Table 125. Antiretroviral Agent Typical Customers
    Table 126. Antiretroviral Agent Typical Distributors
List of Figure
    Figure 1. Antiretroviral Agent Picture
    Figure 2. World Antiretroviral Agent Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Antiretroviral Agent Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Antiretroviral Agent Production (2019-2030) & (K Units)
    Figure 5. World Antiretroviral Agent Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Antiretroviral Agent Production Value Market Share by Region (2019-2030)
    Figure 7. World Antiretroviral Agent Production Market Share by Region (2019-2030)
    Figure 8. North America Antiretroviral Agent Production (2019-2030) & (K Units)
    Figure 9. Europe Antiretroviral Agent Production (2019-2030) & (K Units)
    Figure 10. China Antiretroviral Agent Production (2019-2030) & (K Units)
    Figure 11. Japan Antiretroviral Agent Production (2019-2030) & (K Units)
    Figure 12. Antiretroviral Agent Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 15. World Antiretroviral Agent Consumption Market Share by Region (2019-2030)
    Figure 16. United States Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 17. China Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 18. Europe Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 19. Japan Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 22. India Antiretroviral Agent Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Antiretroviral Agent by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Antiretroviral Agent Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Antiretroviral Agent Markets in 2023
    Figure 26. United States VS China: Antiretroviral Agent Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Antiretroviral Agent Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Antiretroviral Agent Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Antiretroviral Agent Production Market Share 2023
    Figure 30. China Based Manufacturers Antiretroviral Agent Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Antiretroviral Agent Production Market Share 2023
    Figure 32. World Antiretroviral Agent Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Antiretroviral Agent Production Value Market Share by Type in 2023
    Figure 34. Nucleoside Reverse Transcriptase Inhibitors
    Figure 35. Protease Inhibitors
    Figure 36. HIV Integrase Strand Transfer Inhibitors
    Figure 37. Non-Nucleoside Reverse Transcriptase Inhibitors
    Figure 38. Entry Inhibitors—CCR5 Co-Receptor Antagonist
    Figure 39. Fusion Inhibitors
    Figure 40. Others
    Figure 41. World Antiretroviral Agent Production Market Share by Type (2019-2030)
    Figure 42. World Antiretroviral Agent Production Value Market Share by Type (2019-2030)
    Figure 43. World Antiretroviral Agent Average Price by Type (2019-2030) & (US$/Unit)
    Figure 44. World Antiretroviral Agent Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 45. World Antiretroviral Agent Production Value Market Share by Application in 2023
    Figure 46. Hospital Pharmacies
    Figure 47. Retail Pharmacies
    Figure 48. Online Pharmacies
    Figure 49. Others
    Figure 50. World Antiretroviral Agent Production Market Share by Application (2019-2030)
    Figure 51. World Antiretroviral Agent Production Value Market Share by Application (2019-2030)
    Figure 52. World Antiretroviral Agent Average Price by Application (2019-2030) & (US$/Unit)
    Figure 53. Antiretroviral Agent Industry Chain
    Figure 54. Antiretroviral Agent Procurement Model
    Figure 55. Antiretroviral Agent Sales Model
    Figure 56. Antiretroviral Agent Sales Channels, Direct Sales, and Distribution
    Figure 57. Methodology
    Figure 58. Research Process and Data Source

Companies Mentioned

ViiV Healthcare
Gilead Sciences
GlaxoSmithKline
Merck Sharp and Dohme
Bristol-Myers Squibb
Janssen Pharmaceuticals
Pfizer
Boehringer Ingelheim
AbbVie
Genentech
Mylan